Prana Biotechnology Limited (ADR) (PRAN) news: Alzheimer's Dementia: Eli ... Seeking Alpha In this article I will be analyzing the differences between Eli Lilly's (LLY) Solanezumab and Prana Biotechnology's (PRAN) PBT2 -- the new leading candidates in the treatment of Alzheimer's dementia and the implications for their development. Funding ... |